Calamos Advisors’s Boston Scientific BSX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $107M | Buy |
1,000,279
+30,311
| +3% | +$3.26M | 0.42% | 37 |
|
2025
Q1 | $97.9M | Sell |
969,968
-57,089
| -6% | -$5.76M | 0.43% | 37 |
|
2024
Q4 | $91.7M | Buy |
1,027,057
+4,509
| +0.4% | +$403K | 0.38% | 44 |
|
2024
Q3 | $85.7M | Sell |
1,022,548
-9,364
| -0.9% | -$785K | 0.37% | 47 |
|
2024
Q2 | $79.5M | Sell |
1,031,912
-50,741
| -5% | -$3.91M | 0.35% | 47 |
|
2024
Q1 | $74.2M | Sell |
1,082,653
-37,911
| -3% | -$2.6M | 0.35% | 58 |
|
2023
Q4 | $64.8M | Sell |
1,120,564
-4,939
| -0.4% | -$286K | 0.31% | 72 |
|
2023
Q3 | $59.4M | Buy |
1,125,503
+2,499
| +0.2% | +$132K | 0.31% | 71 |
|
2023
Q2 | $60.7M | Buy |
1,123,004
+42,983
| +4% | +$2.32M | 0.3% | 71 |
|
2023
Q1 | $54M | Sell |
1,080,021
-128,640
| -11% | -$6.44M | 0.26% | 94 |
|
2022
Q4 | $55.9M | Sell |
1,208,661
-112,498
| -9% | -$5.21M | 0.26% | 91 |
|
2022
Q3 | $51.2M | Sell |
1,321,159
-3,026
| -0.2% | -$117K | 0.23% | 99 |
|
2022
Q2 | $49.4M | Buy |
1,324,185
+102,122
| +8% | +$3.81M | 0.21% | 107 |
|
2022
Q1 | $54.1M | Buy |
1,222,063
+105,492
| +9% | +$4.67M | 0.2% | 114 |
|
2021
Q4 | $47.4M | Buy |
1,116,571
+21,444
| +2% | +$911K | 0.18% | 128 |
|
2021
Q3 | $47.5M | Sell |
1,095,127
-55,354
| -5% | -$2.4M | 0.21% | 115 |
|
2021
Q2 | $49.2M | Buy |
1,150,481
+139,973
| +14% | +$5.99M | 0.22% | 102 |
|
2021
Q1 | $39.1M | Buy |
1,010,508
+280,323
| +38% | +$10.8M | 0.21% | 111 |
|
2020
Q4 | $26.3M | Buy |
730,185
+19,257
| +3% | +$692K | 0.15% | 162 |
|
2020
Q3 | $27.2M | Sell |
710,928
-46,405
| -6% | -$1.77M | 0.17% | 141 |
|
2020
Q2 | $26.6M | Sell |
757,333
-389,033
| -34% | -$13.7M | 0.19% | 144 |
|
2020
Q1 | $37.4M | Buy |
1,146,366
+893,345
| +353% | +$29.1M | 0.29% | 95 |
|
2019
Q4 | $11.4M | Sell |
253,021
-7,913
| -3% | -$358K | 0.06% | 299 |
|
2019
Q3 | $10.6M | Buy |
+260,934
| New | +$10.6M | 0.06% | 306 |
|